This article summarizes the major advances in TAVR published or reported in 2015 for patients with severe symptomatic aortic stenosis at high or extreme surgical risk.
Offers 2015-era TAVR summary for high-risk aortic stenosis; leaves open need for updated syntheses incorporating later trials and devices.
Transcatheter aortic valve replacement (TAVR) has emerged as an attractive option for patients with severe symptomatic aortic stenosis (AS) who are either at high risk or extreme risk for surgical aortic valve replacement (SAVR). This article summarizes the major advances in TAVR that were published or reported in 2015.
No takes yet. Share an insight, caveat, or question.
Harjai et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
More on Transcatheter aortic valve replacementMore from Journal of Interventional Cardiology